Shijiazhuang Yiling Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shijiazhuang Yiling Pharmaceutical Co Ltd with three other
companies in this sector in China:
Tianjin Chase Sun Pharmaceutical Company Limited
sales of 3.87 billion Chinese Renmimbi [US$583.80 million]
of which 49%
JiangSu Bicon Pharmaceutical Listed Co
(3.72 billion Chinese Renmimbi [US$562.18 million]
of which 65%
was Pharmaceutical Intermediates), and
Shenzhen Salubris Pharmaceuticals Co Ltd
(3.83 billion Chinese Renmimbi [US$578.74 million]
of which 100%
was Pharmaceutical Manufacturing).
Shijiazhuang Yiling Pharmaceutical Co Ltd reported sales of 3.82 billion Chinese Renmimbi (US$576.71 million)
December of 2016.
increase of 20.0%
versus 2015, when the company's sales were 3.18 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Shijiazhuang Yiling Pharmaceutical Co Ltd.